Russell Cox

Russell Cox

Director/Board Member at GOSSAMER BIO, INC.

Net worth: 13 916 $ as of 2024-04-29

60 year
Health Technology
Consumer Services
Producer Manufacturing

Network origin in Russell Cox first degree

EntityEntity typeIndustry
Texas A&M University
279
College/University Other Consumer Services 279
143
Subsidiary Biotechnology 143
Public Company Biotechnology 43
Public Company Pharmaceuticals: Major 40
31
Subsidiary Pharmaceuticals: Major 31
Public Company Pharmaceuticals: Major 29
18
Subsidiary Pharmaceuticals: Major 18
15
Extinct Pharmaceuticals: Major 15
9
Holding Company Pharmaceuticals: Major 9
6
Extinct Pharmaceuticals: Major 6
1
Non-Profit Organization Miscellaneous Commercial Services 1
1
Subsidiary Industrial Machinery 1
Public Company Pharmaceuticals: Major 1

Chart of Companies connected to the second degree

Multi-company connection

Companies connected to Russell Cox via their personal network

CompanySectorRelated peopleMain position
University of California, Berkeley College/University

Karen Wilson

David Nagler

Kristina Burow

Carol A. Gamble

Duane Nash

Armen Shanafelt

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Graduate Degree

Graduate Degree

Doctorate Degree

CELGENE Biotechnology

Kristina Burow

Thomas Daniel

Hunter Smith

Christian Waage

Sandy Mahatme

Deanna Weber

Director/Board Member

President

Corporate Officer/Principal

Corporate Officer/Principal

Director of Finance/CFO

Human Resources Officer

RECEPTOS INC Pharmaceuticals: Major

Faheem Hasnain

Kristina Burow

Christian Waage

Sheila Gujrathi

Richard Aranda

Chief Executive Officer

Founder

General Counsel

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

AMGEN INC. Pharmaceuticals: Major

Kathryn Falberg

G. Kirk Raab

Thomas Daniel

Sandra Milligan

Jeff Boerneke

Director of Finance/CFO

Director/Board Member

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

General Counsel

CORCEPT THERAPEUTICS INCORPORATED Pharmaceuticals: Major

Patrick Enright

Daniel Swisher

Steven Lo

Renée Galá

Director/Board Member

Director/Board Member

Corporate Officer/Principal

Director/Board Member

BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Faheem Hasnain

Sundeep Dugar

Sheila Gujrathi

Richard Aranda

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Massachusetts Institute of Technology College/University

Suzanne Bruhn

Arthur Levinson

John Quisel

Jeffrey Goldberg

Doctorate Degree

Director/Board Member

Doctorate Degree

Graduate Degree

Medical Specialties

Jean-Jacques Bienaimé

Alison Lawton

Jeffrey Albers

Jeffrey Goldberg

Director/Board Member

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

The Wharton School of the University of Pennsylvania College/University

Jean-Jacques Bienaimé

Patrick Enright

Matthew Young

Sara Brownstein

Masters Business Admin

Masters Business Admin

Masters Business Admin

Undergraduate Degree

College/University

Richard B. Brewer

Muneer Satter

Hunter Smith

Sheila Gujrathi

Masters Business Admin

Director/Board Member

Undergraduate Degree

Undergraduate Degree

ALZA CORPORATION Pharmaceuticals: Major

Daniel Swisher

Carol A. Gamble

Jeffrey K. Tobias

Valerie Pierce

Sales & Marketing

General Counsel

Corporate Officer/Principal

General Counsel

AXCA HEALPAR Biotechnology

Ivana Magovcevic-Liebisch

Catherine Sohn

Paul Fehlner

Heidy Abreu King-Jones

Corporate Officer/Principal

Director/Board Member

General Counsel

General Counsel

APOGEE THERAPEUTICS, INC. Biotechnology

Tomas Kiselak

Peter Harwin

Michael Henderson

Mark Mckenna

Director/Board Member

Director/Board Member

Chief Executive Officer

Chairman

College/University

Bryan Cressey

George F. Schreiner

John Quisel

Michael Henderson

Masters Business Admin

Doctorate Degree

Undergraduate Degree

Undergraduate Degree

Harvard Law School College/University

Bryan Cressey

Muneer Satter

John Quisel

Graduate Degree

Graduate Degree

Graduate Degree

Biotechnology

Jean-Jacques Bienaimé

Norbert Riedel

V. Lawlis

Chief Executive Officer

Director/Board Member

Corporate Officer/Principal

Investment Managers

Ivana Magovcevic-Liebisch

John Quisel

Jeffrey Albers

Consultant / Advisor

Consultant / Advisor

Private Equity Investor

Trinity College Dublin College/University

Peter Gray

Seamus Mulligan

Fintan Keegan

Graduate Degree

Graduate Degree

Undergraduate Degree

The University of Texas at Austin College/University

V. Lawlis

Thomas Daniel

Cortney Caudill

Undergraduate Degree

Doctorate Degree

Undergraduate Degree

Investment Managers

Paul Berns

Kristina Burow

Thomas Daniel

Private Equity Analyst

Private Equity Investor

Private Equity Analyst

BIOMARIN PHARMACEUTICAL INC. Biotechnology

Jean-Jacques Bienaimé

Kathryn Falberg

V. Lawlis

Chief Executive Officer

Director/Board Member

Director/Board Member

PROTAGONIST THERAPEUTICS, INC. Biotechnology

Daniel Swisher

Armen Shanafelt

Bryan Giraudo

Director/Board Member

Director/Board Member

Director/Board Member

College/University

Bryan Cressey

Arthur Levinson

Cameron Turtle

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Pharmaceuticals: Major

Arthur Levinson

Jean-Jacques Bienaimé

Thomas Daniel

Director/Board Member

Director/Board Member

Director/Board Member

NGM BIOPHARMACEUTICALS, INC. Biotechnology

Arthur Levinson

Suzanne Hooper

Valerie Pierce

Director/Board Member

Director/Board Member

Compliance Officer

Medical/Nursing Services

Faheem Hasnain

Thomas Daniel

Caryn Peterson

Chairman

Director/Board Member

Director/Board Member

PDL BIOPHARMA, INC. Biotechnology

Faheem Hasnain

Karen Wilson

Ami Knoefler

Chief Executive Officer

Director of Finance/CFO

Public Communications Contact

AMBRX INC Pharmaceuticals: Major

Thomas Daniel

Sheila Gujrathi

Deanna Weber

Chief Tech/Sci/R&D Officer

Director/Board Member

Human Resources Officer

University of California, Los Angeles College/University

Kathryn Falberg

Wendy Hitchcock

Scott Burrows

Undergraduate Degree

Masters Business Admin

Masters Business Admin

Miscellaneous Commercial Services

Arthur Levinson

Jean-Jacques Bienaimé

G. Kirk Raab

Director/Board Member

Director/Board Member

Chairman

Stanford University College/University

Patrick Enright

John Quisel

Michael Henderson

Undergraduate Degree

Graduate Degree

Doctorate Degree

Pharmaceuticals: Major

Renée Galá

Patricia Carr

President

Director/Board Member

Household/Personal Care

Errol Halperin

Muneer Satter

Director/Board Member

Director/Board Member

CYTOMX THERAPEUTICS, INC. Pharmaceuticals: Major

John Scarlett

Matthew Young

Director/Board Member

Director/Board Member

College/University

Cortney Caudill

Paul Fehlner

Masters Business Admin

Graduate Degree

Miscellaneous Commercial Services

Errol Halperin

Christian Waage

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Paul Berns

Kristina Burow

Chief Executive Officer

Director/Board Member

AMYRIS, INC. Chemicals: Specialty

Arthur Levinson

Valerie Pierce

Chairman

Corporate Officer/Principal

NEUMORA THERAPEUTICS, INC. Pharmaceuticals: Major

Paul Berns

Kristina Burow

Founder

Director/Board Member

Georgetown University Law Center College/University

Sandra Milligan

Jim Kastenmayer

Graduate Degree

Graduate Degree

Electronic Equipment/Instruments

Renée Galá

Matthew Young

Director of Finance/CFO

Director of Finance/CFO

INTERMUNE INC Biotechnology

Richard B. Love

Jean-Jacques Bienaimé

Corporate Officer/Principal

Director/Board Member

VAXART, INC. Biotechnology

Karen Wilson

Steven Lo

Director/Board Member

Chief Executive Officer

Pharmaceuticals: Major

Muneer Satter

Duane Nash

Chairman

Director/Board Member

Statistics

International

United States 47
Ireland 5

Sectoral

Health Technology 28
Consumer Services 13
Finance 4
Commercial Services 3
Health Services 2

Operational

Director/Board Member 562
Corporate Officer/Principal 260
Independent Dir/Board Member 198
Chairman 108
Undergraduate Degree 89
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW